Literature DB >> 11931922

Impaired fear conditioning in Alzheimer's disease.

Stephan Hamann1, Elena S Monarch, Felicia C Goldstein.   

Abstract

Classical conditioning of the fear response is a basic form of nondeclarative (nonconscious) memory that mediates both normal and pathological responses to aversive stimuli. Because fear conditioning critically depends on the amygdala, a medial temporal lobe structure that frequently undergoes significant pathological changes early in the course of Alzheimer's disease (AD), we hypothesized that fear conditioning would be impaired in patients with mild to moderate AD. We examined simple classical fear conditioning in a group of 10 patients with probable AD and 14 demographically matched, neurologically intact elderly controls. During conditioning, one stimulus (e.g. a green rectangle, the conditioned stimulus (CS+)), was paired with an aversive stimulus (a loud noise, the unconditioned stimulus (US)) using a partial reinforcement conditioning schedule. The opponent color (e.g. red rectangle), the CS-, was never paired with the US. The elderly controls acquired robust fear responses as demonstrated by their differential skin-conductance responses to the CS+ and CS-. In contrast, the AD group showed a marked impairment in conditioning, failing to exhibit significant conditioned fear responses. This failure to acquire conditioned responses could not be attributed to diminished responding by patients, relative to controls, to the aversive US. The results indicate that fear conditioning, an amygdala-dependent form of memory, is impaired in AD. These findings complement previous reports of impairments in declarative emotional memory in AD by demonstrating that a basic form of nondeclarative emotional memory is also impaired in AD.

Entities:  

Mesh:

Year:  2002        PMID: 11931922     DOI: 10.1016/s0028-3932(01)00223-8

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  43 in total

1.  Gene-environment interplay in affect and dementia: emotional modulation of cognitive expression in personal outcomes.

Authors:  T Palomo; R J Beninger; R M Kostrzewa; T Archer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

2.  Mutual gaze in Alzheimer's disease, frontotemporal and semantic dementia couples.

Authors:  Virginia E Sturm; Megan E McCarthy; Ira Yun; Anita Madan; Joyce W Yuan; Sarah R Holley; Elizabeth A Ascher; Adam L Boxer; Bruce L Miller; Robert W Levenson
Journal:  Soc Cogn Affect Neurosci       Date:  2010-06-29       Impact factor: 3.436

Review 3.  Functional neuroanatomy of amygdalohippocampal interconnections and their role in learning and memory.

Authors:  Alexander J McDonald; David D Mott
Journal:  J Neurosci Res       Date:  2016-02-14       Impact factor: 4.164

4.  Drugs, sweat, and fears: a comparison of the effects of diazepam and methylphenidate on fear conditioning.

Authors:  Catherine M Brignell; H Valerie Curran
Journal:  Psychopharmacology (Berl)       Date:  2006-05-03       Impact factor: 4.530

5.  Rostral-Caudal Hippocampal Functional Convergence Is Reduced Across the Alzheimer's Disease Spectrum.

Authors:  Joseph Therriault; S Wang; S Mathotaarachchi; Tharick A Pascoal; M Parent; T Beaudry; M Shin; Benedet Al; M S Kang; K P Ng; C Dansereau; M T M Park; V Fonov; F Carbonell; E Zimmer; M Mallar Chakravarty; P Bellec; S Gauthier; P Rosa-Neto
Journal:  Mol Neurobiol       Date:  2019-06-22       Impact factor: 5.590

6.  α7-Containing nicotinic acetylcholine receptors on interneurons of the basolateral amygdala and their role in the regulation of the network excitability.

Authors:  Volodymyr I Pidoplichko; Eric M Prager; Vassiliki Aroniadou-Anderjaska; Maria F M Braga
Journal:  J Neurophysiol       Date:  2013-09-04       Impact factor: 2.714

Review 7.  Decision-making cognition in neurodegenerative diseases.

Authors:  Ezequiel Gleichgerrcht; Agustín Ibáñez; María Roca; Teresa Torralva; Facundo Manes
Journal:  Nat Rev Neurol       Date:  2010-10-12       Impact factor: 42.937

Review 8.  Insulin resistance in Alzheimer's disease.

Authors:  Kelly T Dineley; Jordan B Jahrling; Larry Denner
Journal:  Neurobiol Dis       Date:  2014-09-16       Impact factor: 5.996

9.  Cognitive enhancing treatment with a PPARγ agonist normalizes dentate granule cell presynaptic function in Tg2576 APP mice.

Authors:  Miroslav N Nenov; Fernanda Laezza; Sigmund J Haidacher; Yingxin Zhao; Rovshan G Sadygov; Jonathan M Starkey; Heidi Spratt; Bruce A Luxon; Kelly T Dineley; Larry Denner
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

Review 10.  Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines.

Authors:  Daniela Puzzo; Linda Lee; Agostino Palmeri; Giorgio Calabrese; Ottavio Arancio
Journal:  Biochem Pharmacol       Date:  2014-01-21       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.